Skip to main content
. 2019 Jun 3;20(2):995–1006. doi: 10.3892/mmr.2019.10326

Figure 3.

Figure 3.

lncRNA CASC2 was upregulated by berberine treatment in CRC. A-F. RT-qPCR analysis of the six indicated lncRNAs, (A) LINC01018, (B) CASC2, (C) LOC728431, (D) LOC33817, (E) HAR1B, (F) MALAT1, in HT29 cells cultured with berberine-containing medium or berberine-free medium. (G) lncRNA CASC2 expression was measured using RT-qPCR in the indicated cell lines. *P<0.05 vs. FHC cells. (H) lncRNA CASC2 level was detected via RT-qPCR in paired CRC tissues and adjacent non-tumor tissues obtained from patients with CRC. The expression of lncRNA CASC2 was significantly downregulated in primary CRC tissues when compared with noncancerous tissues. (I) lncRNA CASC2 level was increased in HT29 cells following treatment with berberine at increasing concentrations for 48 h. *P<0.05 vs. control cells. lncRNA, long non-coding RNA; CASC2, cancer susceptibility 2; CRC, colorectal cancer; RT-qPCR, reverse-transcription quantitative PC; LINC01018, long intergenic non-protein coding RNA 1018; LOC728431, long intergenic non-protein coding RNA 1137; MALAT1, metastasis associated lung adenocarcinoma transcript 1.